The future for this diagnostic tool is promising
With a group of 454 patients with different types of diagnoses, the new blood test had 100% specificity for ovarian cancer, it outperformed CA-125, and it worked regardless of patients’ age, stage of the cancer, as well a personal and family history. “We might now have a blood test that allows us to detect ovarian cancer. CA-125 has proven to be inadequate to detect ovarian cancer. It’s a test that, when you have the disease, it is good to help monitor. A diagnostic could make a huge difference in survival rates. This is a blood test that has potential to be an early diagnostic tool for ovarian cancer,” said Chowdhury. “It’s proof of concept that this may work, but we do not have a test yet,” he added.